Browse our anti-MAP3K14 (MAP3K14) Antibodies

Full name:
anti-Mitogen-Activated Protein Kinase Kinase Kinase 14 Antibodies (MAP3K14)
On are 92 Mitogen-Activated Protein Kinase Kinase Kinase 14 (MAP3K14) Antibodies from 17 different suppliers available. Additionally we are shipping MAP3K14 Proteins (7) and many more products for this protein. A total of 107 MAP3K14 products are currently listed.
aly, F23F1.4, F23F1_4, FTDCR1B, HS, HSNIK, mitogen-activated protein kinase kinase kinase 14, Nik
list all antibodies Gene Name GeneID UniProt
MAP3K14 9020 Q99558
MAP3K14 360640  
MAP3K14 53859 Q9WUL6

Show all species

Show all synonyms

Most Popular Reactivities for anti-MAP3K14 (MAP3K14) Antibodies

Select your species and application

anti-Human MAP3K14 Antibodies:

anti-Rat (Rattus) MAP3K14 Antibodies:

anti-Mouse (Murine) MAP3K14 Antibodies:

All available anti-MAP3K14 Antibodies

Go to our pre-filtered search.

Top referenced anti-MAP3K14 Antibodies

  1. Mouse (Murine) Polyclonal MAP3K14 Primary Antibody for WB - ABIN658077 : Bhattacharyya, Borthakur, Dudeja, Tobacman: Lipopolysaccharide-induced activation of NF-κB non-canonical pathway requires BCL10 serine 138 and NIK phosphorylations. in Experimental cell research 2010 (PubMed)
    Show all 4 references for 658077

  2. Human Polyclonal MAP3K14 Primary Antibody for EIA, IHC (p) - ABIN360384 : Andreakos, Smith, Monaco, Brennan, Foxwell, Feldmann: Ikappa B kinase 2 but not NF-kappa B-inducing kinase is essential for effective DC antigen presentation in the allogeneic mixed lymphocyte reaction. in Blood 2003 (PubMed)
    Show all 3 references for 360384

More Antibodies against MAP3K14 Interaction Partners

Human Mitogen-Activated Protein Kinase Kinase Kinase 14 (MAP3K14) interaction partners

  1. OLFM1 (show OLFM1 Antibodies) is a negative regulator of non-canonical NF-kappaB (show NFKB1 Antibodies) signalling by interacting with and inhibiting NIK. Thus, OLFM1 (show OLFM1 Antibodies) may serve as a valuable biomarker and therapeutic target for colorectal cancer (CRC (show CALR Antibodies)) patients.

  2. The expression of OTUD7B (show OTUD7B Antibodies) and NIK were negatively correlated in non-small cell lung cancer tumor samples. the higher expression of NIK was related to more lymph node metastasis and later TNM (show ODZ1 Antibodies) stage. high OTUD7B (show OTUD7B Antibodies)/low NIK index can predict an good prognosis.

  3. NIK expression was significantly increased in the tumor tissue of patients with breast carcinoma, which may be an important factor that affects the prognosis of these patients.

  4. This study identified two novel independent loci (MAP3K14 and CARD9 (show CARD9 Antibodies)) strongly associated with joint damage in Mexican Americans and European Americans and a few shared loci showing suggestive evidence for association.

  5. The forced expression of NDRG2 (show NDRG2 Antibodies) in ATL cells down-regulates not only the canonical pathway by inhibiting AKT (show AKT1 Antibodies) signaling but also the non-canonical pathway by inducing NF-kappaB (show NFKB1 Antibodies)-inducing kinase (NIK) dephosphorylation via the recruitment of PP2A (show PPP2R4 Antibodies)

  6. NIK(+) endothelial cells may play an important role in the persistence of synovitis

  7. Data suggest microRNA302c, but not microRNA520e, promotes replication of influenza A virus H3N2 although the two microRNAs target same site of NFkappaB (show NFKB1 Antibodies)-inducing kinase (MAP3K14) 3prime untranslated region; studies were conducted in lung epithelial cells.

  8. TWEAK (show TNFSF12 Antibodies) induces noncanonical NF-kappaB (show NFKB1 Antibodies) signaling and signal-specific regulation of NIK mRNA expression.

  9. by demonstrating a critical role of NIK in mediating NF-kappaB (show NFKB1 Antibodies) activation and BAG3 (show BAG3 Antibodies) induction upon ST80/Bortezomib cotreatment, our study provides novel insights into mechanisms of resistance to proteotoxic stress in RMS

  10. Loss-of-function mutations in NIK can cause B-cell lymphopenia, hypogammaglobulinemia, impaired ICOSL (show ICOSLG Antibodies) expression, and disordered T helper cell and NK cell function.

Mouse (Murine) Mitogen-Activated Protein Kinase Kinase Kinase 14 (MAP3K14) interaction partners

  1. this study demonstrates that although NIK (show MAP4K4 Antibodies) is dispensable for thymocyte development, it has a cell-intrinsic role in regulating the homeostasis and function of peripheral T cells

  2. Using a novel conditional mutant of NIK (show MAP4K4 Antibodies), the authors could show in vivo that NIK (show MAP4K4 Antibodies) signaling in thymic epithelial cells is essential for the thymic hardwiring of gammadelta T cell cytokine production.

  3. NIK (show MAP4K4 Antibodies) not only contributes to lymphoid organogenesis, inflammation and cell survival but also to TNFR1 (show TNFRSF1A Antibodies)/RIP1 (show RALBP1 Antibodies)-dependent cell death independently of the alternative NF-kappaB (show NFKB1 Antibodies) pathway.

  4. This study demonstrated that NFkappaB-inducing kinase inhibits NFkappaB activity specifically in neurons of the CNS.

  5. results assign NIK (show MAP4K4 Antibodies)-induced alternative NF-kappaB (show NFKB1 Antibodies) signaling a master regulatory role in B-cells, starting from the T1 stage and also show that B-1 B cells are less dependent on this pathway, presumably owing to the existence of alternative pathways yet to be determined

  6. NIK (show MAP4K4 Antibodies), and thus probably the noncanonical NF-kappaB (show NFKB1 Antibodies) pathway, is critical to allow DCs to acquire the capacity to cross-present antigen and prime CD8 (show CD8A Antibodies) T cells after exposure to licensing stimuli.

  7. Deletion of NIK (show MAP4K4 Antibodies) in adult mice results in decreases in B cell populations in lymph nodes and spleen, similar to what is observed upon blockade of BAFF (show TNFSF13B Antibodies).

  8. We identify NIK (show MAP4K4 Antibodies) as a critical negative regulator of beta cell function, as pharmacological NIK (show MAP4K4 Antibodies) activation results in impaired glucose-stimulated insulin (show INS Antibodies) secretion in mouse and human islets.

  9. the NIK (show MAP4K4 Antibodies) in thymic stroma may be critically involved in the differentiation of most NKT (show CTSL1 Antibodies) cell subsets (although the level of NIK (show MAP4K4 Antibodies) dependence may vary among the subsets), and also the NIK (show MAP4K4 Antibodies) in NKT (show CTSL1 Antibodies)-alphabeta cells may be dispensable for their effector function.

  10. CHIP/TRAF3 (show TRAF3 Antibodies)/NIK (show MAP4K4 Antibodies) interactions recruit NIK (show MAP4K4 Antibodies) to E3 ligase complexes for ubiquitination and degradation, thus maintaining NIK (show MAP4K4 Antibodies) at low levels

MAP3K14 Antigen Profile

Antigen Summary

This gene encodes mitogen-activated protein kinase kinase kinase 14, which is a serine/threonine protein-kinase. This kinase binds to TRAF2 and stimulates NF-kappaB activity. It shares sequence similarity with several other MAPKK kinases. It participates in an NF-kappaB-inducing signalling cascade common to receptors of the tumour-necrosis/nerve-growth factor (TNF/NGF) family and to the interleukin-1 type-I receptor.

Alternative names and synonyms associated with MAP3K14

  • mitogen-activated protein kinase kinase kinase 14 (MAPKKK14) antibody
  • mitogen-activated protein kinase kinase kinase 14 (MAP3K14) antibody
  • mitogen-activated protein kinase kinase kinase 14 (Map3k14) antibody
  • aly antibody
  • F23F1.4 antibody
  • F23F1_4 antibody
  • FTDCR1B antibody
  • HS antibody
  • HSNIK antibody
  • mitogen-activated protein kinase kinase kinase 14 antibody
  • Nik antibody

Protein level used designations for MAP3K14

NF-kappa-beta-inducing kinase , serine/threonine protein-kinase , serine/threonine-protein kinase NIK , NF kappa B-inducing kinase , Nfkb inducing kinase , alymphoplasia , protein kinase

817555 Arabidopsis thaliana
9020 Homo sapiens
360640 Rattus norvegicus
53859 Mus musculus
Selected quality suppliers for anti-MAP3K14 (MAP3K14) Antibodies
Did you look for something else?